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Abstract
Background: Gene transfer using non-viral vectors offers a non-immunogenic and safe method of gene delivery.
Cellular uptake and intracellular trafficking of the nanoparticles can impact on the transfection efficiency of these
vectors. Therefore, understanding the physicochemical properties that may influence the cellular uptake and the
intracellular trafficking can aid the design of more efficient non-viral gene delivery systems. Recently, we developed
novel amino acid-substituted gemini surfactants that showed higher transfection efficiency than their parent
compound. In this study, we evaluated the mechanism of cellular uptake of the plasmid/gemini surfactant/helper
lipid nanoparticles and their effect on the transfection efficiency.
Results: Nanoparticles were incubated with Sf 1 Ep cells in the presence of different endocytic inhibitors and gene
expression (interferon-g) was measured using ELISA. Clathrin-mediated and caveolae-mediated uptake were found
to be equally contributing to cellular internalization of both P/12-7NH-12/L (parent gemini surfactant) and P/12-
7NGK-12/L (amino acid-substituted gemini surfactant) nanoparticles. The plasmid and the helper lipid were
fluorescently tagged to track the nanoparticles inside the cells, using confocal laser scanning microscopy.
Transmission electron microscopy images showed that the P/12-7NGK-12/L particles were cylindrical while the P/
12-7NH-12/L particles were spherical which may influence the cellular uptake behaviour of these particles. Dye
exclusion assay and pH-titration of the nanoparticles suggested that high buffering capacity, pH-dependent
increase in particle size and balanced DNA binding properties may be contributing to a more efficient endosomal
escape of P/12-7NGK-12/L compared to the P/12-7NH-12/L nanoparticles, leading to higher gene expression.
Conclusion: Amino-acid substitution in the spacer of gemini surfactant did not alter the cellular uptake pathway,
showing similar pattern to the unsubstituted parent gemini surfactant. Glycyl-lysine substitution in the gemini
spacer improved buffering capacity and imparted a pH-dependent increase of particle size. This property conferred
to the P/12-7NGK-12/L nanoparticles the ability to escape efficiently from clathrin-mediated endosomes. Balanced
binding properties (protection and release) of the 12-7NGK-12 in the presence of polyanions could contribute to
the facile release of the nanoparticles internalized via caveolae-mediated uptake. A more efficient endosomal
escape of the P/12-7NGK-12/L nanoparticles lead to higher gene expression compared to the parent gemini
surfactant.
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Gene therapy is based on the delivery of therapeutic
genes to prevent or treat a disease. The method includes
replacing a nonfunctional gene, introducing a new or
missing gene, silencing a gene, or regulating gene
expression. Gene-based therapy could offer an improved
therapeutic solution and a cost-effective option to the
treatment of many diseases, including cancer and infec-
tious diseases [1,2]. Among the available gene transfer
technologies, non-viral vectors offer a non-immunogenic
and safe method of gene delivery. However, they have
generally lower transfection efficiency compared to their
viral counterparts.
For successful gene expression, a delivery vector needs
to overcome three major challenges (Figure 1): cellular
uptake, endosomal/lysosomal escape and nuclear locali-
zation [3]. Cellular uptake is an important process, as it
determines the number of particles that are internalized
and available for gene expression. Moreover, the
mechanism of uptake may determine the intracellular
pathway and the final fate of the vectors [4]. Clathrin-
mediated, caveolae-mediated uptake and macropinocyto-
sis are the most common uptake pathways utilized by
mammalian cells to engulf macromolecules or solutes
impermeable to plasma membrane [4]. We assessed the
effect of these three cellular uptake pathways on the gene
transfer efficiency of the gemini surfactant-based nano-
particles. The clathrin-mediated uptake involves special
membrane structures called clathrin-coated pits [5].
When ligands bind to these receptors, the coated pits
form a polygonal clathrin lattice with the help of adaptor
proteins. These clathrin-coated pits are pinched off from
the plasma membrane and internalized to form intracel-
lular clathrin-coated vesicles ranging in size from 100 to
150 nm in diameter [5]. Inside the cell, the clathrin coat
depolymerizes to form early endosomes which then fuse
with late endosomes and proceed to finally fuse with
lysosomes. Particles internalized via this pathway experi-
ence a drop in pH, towards acidic conditions (pH 5-6), as
they travel towards late endosomes, before merging with
lysosomes [6]. Chlorpromazine and potassium depletion
can dissociate clathrin from the surface membrane and
inhibit clathrin-mediated endocytosis [7,8]. Caveolae-
mediated uptake is another important pathway that
involves small hydrophobic domains that are rich in cho-
lesterol and glycosphingolipids [9]. Contrary to clathrin-
mediated uptake, the caveolae-dependent pathway fol-
lows a non-acidic and non-digestive intracellular route.
Filipin III inhibits caveolae-mediated uptake by binding
to 3b-hydroxysterol, a major component of glycolipid
microdomains and caveolae [10]. Genistein also inhibits
caveolae-mediated uptake by local disruption of the actin
network and by preventing the recruitment of dynamin
II, both necessary for this type of cellular uptake [11].
Water-soluble methyl-b-cyclodextrin forms inclusion
complexes with cholesterol and is known to inhibit both
clathrin-mediated and caveolae-dependent uptake by
depleting cholesterol from the plasma membrane
[12-14]. Macropinocytosis is a non-selective internaliza-
tion of large volumes of extracellular medium through
cell membrane protrusions that collapse onto and fuse
with the cell membrane [15]. The large endocytic vesicles
are neither coated nor concentrated before internaliza-
tion. Phosphatidylinositol 3 kinase and rho family
GTPase activities influence macropinocytosis by regulat-
ing actin rearrangements. Wortmannin, a phosphatidyli-
nositol 3 kinase inhibitor, can be employed to inhibit
macropinocytosis [16].
Understanding the physicochemical properties of the
gene delivery vectors in association with these uptake
pathways can lead to rational design of nanoparticles
that target those pathways and improve the intracellular
fate of the particles. For example, the design of delivery
agents that respond to the change in pH to escape from
endosomes so as to evade degradation in lysosomes can
improve the transfection efficiency of these non-viral
vectors [17]. To capitalize on the pH sensitivity of these
nanoparticles, clathrin-mediated uptake should be tar-
geted to utilize this phenomenon.
Figure 1 Intracellular trafficking of DNA-delivery vector
complexes. This schematic representation indicates the critical
barriers in successful gene delivery: cellular uptake, endosomal
escape and nuclear localization. A delivery vector interacts with the
cell membrane for internalization. Once inside the cell, the delivery
vector should facilitate endosomal escape and avoid DNA
degradation in lysosomes. Cytoplasmic stability of plasmid DNA and
localization in the nucleus are final steps to successful gene transfer.
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of cationic N,N-bis(dimethylalkyl)-a,ω-alkanediammo-
nium gemini surfactants or m-s-m; where m and s refer
to the number of carbon atoms in the alkyl tails and in
the polymethylene spacer groups, respectively [18,19].
More recently, a series of third generation gemini sur-
factants have been developed by introducing an amino
acid/dipeptide group at the N position of the spacer of a
previously studied compound (12-7NH-12) (Figure 2A).
The glycyl-lysine substituted derivative (12-7NGK-12,
Figure 2B) achieved the highest gene expression among
the series, performing significantly better than the
unsubstituted parent compound [20,21].
In this study, we evaluated the cellular uptake beha-
vior of plasmid/gemini/lipid (P/G/L) nanoparticles and
investigated their impact on the transfection efficiency
of these nanoparticles. We also explored the physico-
chemical properties that may have led to the difference
in cellular uptake and intracellular trafficking of these
nanoparticles resulting in the difference in transfection
efficiency between these vectors.
Materials and methods
Reagents for uptake studies
Genistein, filipin III, methyl-b-cyclodextrin, chlorproma-
zine hydrochloride and wortmannin were purchased
from Sigma-Aldrich, Oakville, Canada.
Formulations
A model plasmid pGT.IFN-GFP that encodes for inter-
feron (IFN)-g and green fluorescent protein was used for
all formulations. Gemini surfactants were formulated
with pGT.IFN-GFP in the presence of a helper lipid 1,2-
dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE;
Avanti Polar Lipids, AL, U.S.A.) creating P/G/L nano-
particles. A plasmid to gemini surfactant charge ratio of
1:10 was used for all formulations (as described earlier
[20]). A quantity of 100 ng plasmid DNA per well was
used in the 96-well plates for transfection.
Cell culture and propagation
Cotton tail rabbit epithelial cells, Sf 1 Ep (CCL-68,
ATCC, VA, USA) were grown in Minimum Essential
Medium (MEM, GIBCO, NY, USA) supplemented with
10% fetal bovine serum and antibiotic/antimycotic
agents, respectively. All cells were grown to 70-80% con-
fluency. The cells were seeded at a concentration of
20,000 cells per well in 96-well tissue culture plates (Fal-
con BD, Mississauga, Canada) and were incubated for
24 hours at 37°C/5% CO2 prior to transfection.
Cell toxicity assay
Genistein (200 μM), filipin III (5 μg/ml and 1 μg/ml),
methyl-b-cyclodextrin (10 mM and 5 mM), chlorproma-
zine hydrochloride (10 μg/ml and 5 μg/ml), wortmannin
50 nM were incubated with the cells for 1, 2, 3 and 4
hours [12,22-24]. For potassium depletion, the cells
were washed three times with potassium free buffer
containing 140 mM NaCl, 20 mM Hepes pH 7.4, 1 mM
CaCl2,1m MM g C l 2 and 1 mg/ml D-glucose, followed
by 2 minutes incubation with hypotonic buffer (potas-
sium free buffer diluted with water 1:1) [8,22] for 1, 2, 3
and 4 hours. At the end of the incubation, cells were
washed three times with PBS and incubated with fresh
supplemented media at 37°C/5% CO2 for 24 hours. A
10 μl aliquot of 5 mg/ml (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT, Invitrogen, Bur-
lington, Canada) aqueous solution was added in each
well and the plates were incubated at 37°C/5% CO2 for
3 hours. Supernatants were removed and the cells were
washed with PBS. The formed purple formazan was dis-
solved in 200 μL dimethyl sulfoxide (DMSO, Sigma) on
a plate shaker for 10 minutes. The plates were incubated
for 10 minutes at 37°C to eliminate air bubbles. Absor-
bance was measured at 550 nm using a plate reader
(Biotek Microplate Synergy HT, VT, USA). Cell toxicity
of the chemically treated/potassium depleted cells were
expressed as a percentage of dead cells compared to the
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Figure 2 Chemical structure of gemini surfactants. (A) Parent unsubstituted gemini surfactant (12-7NH-12) and (B) glycyl-lysine substituted
gemini surfactant (12-7NGK-12).
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%deadcells =
Abscontrol − Abstreated
Abscontrol
100
Transfection
In a 96-well plate, cells were incubated (in triplicate) for
30 minutes with genistein 200 μM, methyl-b-cyclodex-
trin 5 mM, wortmannin 50 nM, filipin III 5 μg/ml and
for 60 minutes with filipin III 1 μg/ml, chlorpromazine
hydrochloride 5 μg/ml and potassium free buffer prior
to addition of P/G/L nanoparticles. The nanoparticle
formulations were prepared as described above and
incubated with the cells for 2 hours. After 2 hours, the
media was removed and cells were washed three times
with PBS and replenished with fresh media. Superna-
tants were collected at 24, 48 and 72-hour intervals. At
72 hours, an MTT assay was performed to determine
the combined toxicity of P/G/L nanoparticles and che-
mical treatment/potassium depletion on cell viability.
ELISA was used to detect the IFN-g secreted into the
supernatant and was performed according to the BD
Pharmingen protocol. Protein concentration was calcu-
lated from a standard curve using recombinant IFN-g.
Confocal laser scanning microscopy (CLSM)
The model plasmid pGT.IFN-GFP was labeled with tet-
ramethyl-rhodamine (ex/em wavelengths: 546 nm/576
nm) using Label IT
® Tracker™ Kit (Mirus, WI, U.S.A.)
according to the manufacturer’s protocol. N-(7-nitro-2-
1,3-benzoxadiazol-4-yl) labeled DOPE (ex/em wave-
lengths: 460 nm/535 nm) was purchased from Avanti
Polar Lipids, AL, U.S.A.
P/G/L nanoparticles were prepared as described in
transfections using tetramethyl-rhodamine labeled plas-
mid with 10% of DOPE in the formulation being substi-
tuted with fluorescent tagged DOPE.
Sf 1 Ep cells were treated with chemical inhibitors -
genistein, chlorpromazine, wortmannin and methyl-b-
cyclodextrin as described under the section ‘Transfec-
tion’, prior to incubation with fluorescent P/G/L nano-
particles. Additionally, an aliquot of 30 μMD A P Iw a s
added to the cells for staining the nucleus. After 2
hours, the cells were washed with PBS three times and
images were taken using a Leica TCS SP5 laser scanning
confocal microscope (Leica Microsystems Inc., Benshein,
Germany). LAS AF Lite 2.4.1 (Leica Microsystems CMS
GmbH) and ImageJ 1.44 p (National Institute of Health,
U.S.A.) were used for image processing.
pH titration and particle size measurement
P/12-7NH-12/L and P/12-7NGK-12/L nanoparticles
were prepared as described previously. An MPT-2
autotitrator connected to a ZetaSizer Nano ZS (Malvern
Instruments, Worcestershire, UK) was used to deter-
mine changes in particle size as a function of pH.
Briefly, P/G/L nanoparticles (9 ml) were placed in the
titration cell of the auto-titrator and titrated over basic
(0.05 M NaOH) to acidic (0.1 M HCl) pH range at 0.2-
0.5 pH unit intervals.
DNA/gemini surfactant interactions
Nanoparticles were prepared using plasmid and gemini
surfactants at a +/- charge ratio of 10 in the presence of
DOPE as described earlier, with samples prepared in
quadruplicate. P/G/L nanoparticles were incubated with
ethidium bromide (1 μg/mL) and heparin buffer (20
mM HEPES, 5.2% glucose, 0 U/ml, 5 U/ml, 10 U/ml or
20 U/ml heparin, pH 7.0) for 10 minutes at room tem-
perature. Fluorescence excitation was carried out at 528/
20 nm and emission measured at 590/35 nm using a
multiplate reader (Biotek Microplate Synergy HT, VT,
U.S.A.). The relative fluorescence of the P/G/L com-
plexes was expressed as a percentage of the fluorescence
of a plasmid solution in presence of corresponding (0
U/ml, 5 U/ml, 10 U/ml, 20 U/ml) heparin buffer.
%ﬂuorescence =
(ﬂuorescenceP/G/Lwithheparin − ﬂuorescenceP/G/L)
ﬂuorescenceplasmid inpresenceof buffer
100
Transmission electron microscopy (TEM)
Formulations were prepared as described earlier and
loaded onto formvar-coated 300-mesh copper grids
using 5 μL aliquot of each sample. The samples were
incubated for 2 minutes and the liquid was blotted with
absorbent tissue. The specimens were stained with 1%
phosphotungstic acid for 15 seconds, and blotted with
tissue. The dried samples were examined with a Philips
CM 10 electron microscope at an accelerating voltage of
100 kV, and pictures taken on 31/4″ ×4 ″ Kodak Elec-
tron Microscope Film 4489.
Statistical analyses
Results are expressed as the mean of n ≥ 3±s t a n d a r d
deviation. One way analysis of variance (ANOVA) and
Bonferroni/Dunnett’s-T3 post hoc tests were used for
statistical analyses (PASW Statistics 18.0). Significant
differences were considered at p < 0.05 level.
Results
Toxicity of chemical inhibitors or potassium depletion in
Sf 1 Ep cells
In order to optimize the concentration and the exposure
time of the endocytosis inhibitors, we evaluated their
intrinsic toxicity on Sf 1 Ep cells after 1, 2, 3 and 4
hours of incubation period (Figure 3). With the
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ml chlorpromazine concentrations, toxicity was under
20% at the 3-hour time point. Therefore, we selected a
lower concentration of these inhibitors, 5 mM for
methyl-b-cyclodextrin and 5 μg/ml for chlorpromazine
which retained more than 80% cell viability up to 3
hours.
Combined toxicity of P/G/L nanoparticles and chemical
inhibitors/potassium depletion in Sf 1 Ep cells
The inhibition of endocytosis by chemical treatments is a
reversible process; therefore, it is important to maintain
these inhibitors in cell media while transfecting the cells
with the DNA nanoparticles [7,8,10,12]. Caveolae-
mediated inhibitors (filipin and genistein) with P/12-7NH-
12/L (parent gemini surfactant) exhibited an increase in
cytotoxicity with 20-40% dead cells (Figure 4). In the pre-
sence of P/12-7NGK-12/L (amino acid-substituted gemini
surfactant), filipin caused a 89.1 ± 0.8% cytotoxicity. A
decrease of the filipin concentration to 1 μg/ml did not
improve cell viability significantly (82.4 ± 5.2% dead cells),
thus filipin could not be used as an endocytosis inhibitor
due to the significant combined toxicity with the P/G/L
nanoparticle. However, genistein, another inhibitor of the
caveolae-mediated uptake had a cell toxicity of 41.2 ±
1.1% in the presence of P/12-7NGK-12/L, in the range of
other agents. Methyl-b-cyclodextrin which inhibits both
clathrin- and caveolae- dependent endocytosis also
increased cytotoxicity with 26.3 ± 8.9% and 40.6 ± 5.4%
cell death in presence of P/12-7NH-12/L and P/12-7NGK-
12/L nanoparticles, respectively.
Clathrin-mediated uptake inhibition (potassium deple-
tion, chlorpromazine) along with P/G/L nanoparticles
showed an increase in toxicity to 20-45% cell death. In
potassium depleted cells, the cytotoxicity values were
44.6 ± 4.8% of dead cells in the presence of P/12-7NH-
12/L and 43.8 ± 4.7% dead cells after treatment with P/
12-7NGK-12/L. Cytotoxicity was 26.6 ± 8.9% in cells
incubated with chlorpromazine and P/12-7NH-12/L,
while it was 37.9 ± 4.6% in the presence of P/12-7NGK-
12/L. Wortmannin marginally increased cytotoxicity to
16.1 ± 7.6% and 27.2 ± 6.5% in the presence of P/12-
7NH-12/L and P/12-7NGK-12/L, respectively. With the
exception of filipin in the presence of P/12-7NGK-12/L,
the cell toxicity among endocytosis inhibitors was not
significantly different, thus their intrinsic toxicity was
not considered as a modifying factor in gene expression.
Due to the higher toxicity of filipin, genistein was
selected to correlate gene expression to the caveolae-
dependent pathway of the P/12-7NGK-12/L
nanoparticles.
Cellular uptake of P/G/L nanoparticles in cells treated
with chemical inhibition/potassium depletion
P/G/L nanoparticles were prepared using TM-rhoda-
mine (red) labeled plasmid in the presence of fluores-
cent (green) labeled helper lipid. DAPI (blue) was used
as fluorescent stain for the cell nuclei. The objective was
to determine, qualitatively, whether materials were
transferred into the cells and whether the presence of
inhibitors induced a difference in the cellular uptake of
P/12-7NH-12/L and P/12-7NGK-12/L nanoparticles.
Figure 3 Cellular toxicity of the endocytic inhibitors in Sf 1 Ep cells. Cellular toxicity of chemical inhibitors/potassium depletion in Sf 1 Ep
cells was measured at 1, 2, 3 and 4 hours. Conditions regarding concentration of the inhibitor and incubation time that retained cell viability
greater than 80% were selected for cellular uptake study.
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lae-mediated (genistein) or clathrin-mediated (chlorpro-
mazine) uptake pathway did not have any effect on
cellular uptake of P/12-7NGK-12/L or P/12-7NH-12/L
nanoparticles (Figure 5B &5G, 5C &5H). However,
almost no particles were internalized by the cells treated
with either P/12-7NGK-12/L or P/12-7NH-12/L nano-
particles when both clathrin-mediated and caveolae-
mediated uptake pathways were inhibited by prior treat-
ment with methyl-b-cyclodextrin (Figure 5D &5I). This
suggests that both clathrin-mediated and caveolae-
mediated pathways are playing an important role in
uptake of these particles. Wortmannin (Figure 5E &5J)
showed no difference in the cellular uptake of P/12-
7NGK-12/L or P/12-7NH-12/L nanoparticles.
Gene expression of P/G/L nanoparticles in cells treated
with chemical inhibition/potassium depletion
In our previous studies, we found that the amino acid-
substitution on the parent gemini surfactant increased
its transfection efficiency [21]. Here, we evaluated, quan-
titatively, the effect of each uptake pathway on gene
expression of P/12-7NH-12/L and P/12-7NGK-12/L.
Nanoparticles internalized via caveolae-mediated, cla-
thrin-mediated and macropinocytosis encounter differ-
ent intracellular conditions; however, in each case the
particles should escape degrading conditions such as
lysosomes for successful gene expression. The gene
expression levels achieved after inhibiting each cellular
uptake pathway, separately, provides information on effi-
ciency of nanoparticles in escaping these detrimental
conditions.
Caveolae-mediated uptake
In the absence of any inhibitor treatment to the cells,
the gene expression in the P/12-7NH-12/L transfected
cells was 183 ± 17.5 pg IFNg/20000 cells (Figure 6).
Gene expression after P/12-7NH-12/L nanoparticle
transfection was 84 ± 9.4 pg IFNg/20000 cells and 31 ±
14.9 pg IFNg/20000 cells in the presence of genistein
and filipin, respectively, significantly lower (p < 0.05)
compared to the cells treated with the P/G/L in the
absence of the inhibitors.
The cells treated with the glycyl-lysine substituted nano-
particles (P/12-7NGK-12/L), exhibited gene expression of
749 ± 15.2 pg IFNg/20000 cells in the absence of inhibi-
tors. This gene expression was not significantly affected by
inhibition of caveolae-mediated uptake (genistein), exhibit-
ing protein levels of 601 ± 200 pg IFNg/20000 cells. Unfor-
tunately, due to high toxicity of filipin in the presence of
P/12-7NGK-12/L (Figure 4), the gene expression data was
not used for analysis. Methyl-b-cyclodextrin, that inhibits
both clathrin- and caveolae-mediated uptake, reduced sig-
nificantly (p < 0.05) gene expression in cells transfected
with P/12-7NH-12/L and P/12-7NGK-12/L nanoparticles
to 6 ± 2.2 pg IFNg/20000 cells and 50 ± 21.1 pg IFNg/
20000 cells (Figure 6), respectively.
In conclusion, this suggests that caveolae-mediated
uptake was crucial for successful gene expression of P/
Figure 4 Cellular toxicity of the endocytic inhibitors in the presence of P/G/L nanoparticles in Sf 1 Ep cells. Combined cellular toxicity of
P/12-7NH-12/L or P/12-7NGK-12/L in the presence of chemical inhibitors/potassium free buffer in Sf 1 Ep cells was measured at 72 hours. Filipin
had a significantly high combined toxicity; therefore, it was not selected for gene expression study of the P/12-7NGK-12/L nanoparticles.
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Inhibitors  P/12-7NGK-12/L  P/12-7NH-12/L 
No chemicals 
   
Genistein 
     
Chlorpromazine 
   
Methyl-β-cyclodextrin 
   
Wortmannin 
   
A 
B  G 
C  H 
D  I 
E  J 
F 
Figure 5 Laser scanning confocal microscopy (LSCM) images of Sf 1 Ep cells. Cells were pretreated with genistein (B & G), chlorpromazine
(C & H), methyl-b-cyclodextrin (D & I) and wortmannin (E & J). Cells (A to E) were incubated with P/12-7NGK-12/L and Cells (F to J) were
incubated with P/12-7NH-12/L for 2 hours. DAPI was used for staining the cell nuclei. At the end of the study, cells were washed with PBS and
images were recorded. DNA (red), DOPE (green) and cell nuclei (blue).
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caveolae-mediated uptake alone lowered slightly, but not
significantly, the gene expression in the cells transfected
with the P/12-7NGK-12/L nanoparticles.
Clathrin- mediated uptake
It was interesting to note that gene expression of P/12-
7NH-12/L nanoparticles was significantly higher (p <
0.05) after clathrin-mediated uptake inhibition, com-
pared to cells without inhibitors (Figure 6). The gene
expression increased to 483 ± 30.6 pg IFNg/20000 cells
in the cells pre-treated with chlorpromazine. Potassium
depletion, which also inhibits clathrin-mediated uptake,
increased gene expression of P/12-7NH-12/L to 415 ±
70 pg IFNg/20000 cells.
Inhibition of clathrin-mediated uptake by chlorproma-
zine slightly reduced gene expression of P/12-7NGK-12/
L to 613 ± 159 pg IFNg/20000 cells while gene expres-
sion was moderately increased to 1104 ± 235 pg IFNg/
20000 cells after potassium depletion. However, the
effect of inhibition of clathrin-mediated uptake on gene
expression of P/12-7NGK-12/L was not significant com-
pared to cells without inhibitors. As stated above,
inhibition of both clathrin-mediated and caveolae-
mediated uptake with methyl-b-cyclodextrin reduced
the gene expression of P/12-7NGK-12/L significantly
(p < 0.05) compared to the control transfected cells.
In conclusion, P/12-7NH-12/L nanoparticles interna-
lized via clathrin-mediated uptake were not a major
contributor to overall gene expression. On the contrary,
P/12-7NGK-12/L nanoparticles following either clathrin-
or caveolae- mediated pathway resulted in successful
gene expression.
Macropinocytosis
Macropinocytosis inhibitor, wortmannin, did not signifi-
cantly modify gene expression of either P/12-7NH-12/L
or P/12-7NGK-12/L (Figure 6). Protein levels of 121 ±
49 pg IFNg/20000 cells and 606 ± 104 pg IFNg/20000
cells were measured for P/12-7NH-12/L and P/12-
7NGK-12/L, respectively.
Particle size measurement of P/G/L nanoparticles as a
function of pH
The pathway of cellular uptake determines the intracel-
lular fate of the engulfed particle [4]. Cellular
Figure 6 Effect of endocytic inhibitors on gene expression of P/G/L nanoparticles. Interferon (IFN)-g expression was measured at 72 hours
in cells incubated with P/G/L nanoparticles in the presence of endocytic inhibitors. In the P/12-7NH-12/L-treated cells, gene expression in cells pre-
treated with caveolae-mediated uptake inhibitors (genistein, filipin) was significantly lower than the untreated (no inhibitors) cells, whereas gene
expression was significantly higher on inhibiting clathrin-mediated uptake (chlorpromazine). For the P/12-7NGK-12/L nanoparticles, gene
expression was significantly lower in presence of methyl-b-cyclodextrin (clathrin- and caveolae-mediated uptake inhibitor). * represents significant
difference, p < 0.05, compared to ‘No inhibitors’ control cells treated with P/12-7NH-12/L nanoparticles (No inhibitors black bar). $ represents
significant difference, p < 0.05, compared to ‘No inhibitors’ control cells treated with P/12-7NGK-12/L nanoparticles (No inhibitors dashed-line bar).
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somes proceeds with an early influx of H
+ before fusion
w i t ht h el a t ee n d o s o m e ,f i n a lly merging with the lyso-
somes. In order to simulate these conditions, we evalu-
ated the behavior of the P/G/L complexes over the pH
r a n g eo f8 . 0 - 3 . 0 .P a r t i c l es i z ei n c r e a s e di nt h ep Hr a n g e
8.0-5.5 followed by a decreasing trend (Figure 7), fitting
a second order polynomial (quadratic) relationship (R
2 >
0.9) between pH and particle size of P/12-NH-12/L. The
P/12-7NGK-12/L nanoparticles followed a third order
polynomial (cubic) curve exhibiting an exponential
increase in particle size from neutral (~7.4) to acidic
(~4) pH. The increase in particle size of P/12-7NGK-12/
L nanoparticles could be attributed to the accumulation
of H
+ ions due to the higher buffering capacity of the
amino acid-substituted gemini surfactant.
The volume of acid (0.1 M HCl) used per unit pH
value provided a relative comparison of the buffering
ability of 12-7NGK-12 and 12-7NH-12. The pH titration
curve revealed that P/12-7NGK-12/L nanoparticles had
considerably higher buffering capacity than P/12-7NH-
12/L at neutral (~7.4), slightly acidic (6-5) and strongly
acidic (~4) pH values (Figure 8).
Interactions between the DNA and gemini surfactants
Ethidium bromide exclusion assay is a useful technique
to study DNA/delivery vector interaction. The assay was
performed in the presence of the polyanionic heparin,
which competes with DNA to bind with the cationic
gemini surfactants. The interaction between the gemini
surfactants and heparin could cause a dissociation of the
P/G/L complexes, allowing the ethidium bromide to
intercalate in the DNA strand and emit fluorescence.
Lower fluorescence values indicate stronger binding
property of DNA/gemini surfactants and a higher pro-
tection of the genetic material. Also, stronger binding
properties ensure that DNA is not released prematurely,
upon interaction with negatively charged cell surface
proteins.
At the 1:10 charge ratio of DNA and gemini surfac-
tant in the presence of DOPE, a small increase in fluor-
escence (8.9 ± 0.8%) was observed in P/12-7NGK-12/L
nanoparticles upon addition of polyanions (5 U/ml
heparin), exhibiting a stronger protection of DNA com-
pared to the parent gemini surfactant which had an
increase of 52.3 ± 2.3% fluorescence (Figure 9). A simi-
lar trend occurred at higher concentrations of 10 U/ml
and 20 U/ml of heparin. Interestingly, a steady increase
Figure 7 Particle size measurement of P/12-NH-12/L and P/12-
NGK-12/L at different pH. A second order polynomial curve (solid
line) was found to be a best fit (R
2 > 0.9) for P/12-NH-12/L while a
third order polynomial (dashed line) curve (R
2 > 0.9) described the
effect of pH on P/12-NGK-12/L particle size. Stronger acidic
conditions resulted in a significant increase in P/12-NGK-12/L
particle size.
Figure 8 Comparison of buffering capacity of P/G/L
nanoparticles. A pH titration curve of P/G/L nanoparticles
exhibited considerably higher buffering capability of P/12-7NGK-12/L
compared to P/12-7NH-12/L in neutral, slightly acidic and strong
acidic pH.
Figure 9 DNA-gemini surfactant binding properties.A n
ethidium bromide dye exclusion assay was performed to determine
the binding efficiency of 12-7NH-12 and 12-7NGK-12 with plasmid
DNA in the presence of DOPE and heparin (5 U/ml, 10 U/ml and 20
U/ml). At lower concentration of heparin (polyanions), amino-acid
substituted gemini exhibited stronger DNA binding compared to
unsusbtituted gemini surfactant. At higher concentration (20 U/ml
heparin), a significant increase in fluorescence was observed,
indicating dissociation of DNA and 12-7NGK-12.
Singh et al. Journal of Nanobiotechnology 2012, 10:7
http://www.jnanobiotechnology.com/content/10/1/7
Page 9 of 14in fluorescence was observed in P/12-7NGK-12/L nano-
particles with a significant spike in fluorescence (32.9 ±
5.7%) occurring in the presence of 20 U/ml heparin.
This indicates that 12-7NGK-12 has balanced DNA
binding properties which ensures protection of DNA as
well as an ability to interact with a highly negative
charged membrane, such as the inside of caveolae endo-
somes. These balanced binding properties (protection
and release) may be instrumental in efficient endosomal
escape leading to higher transfection efficiency of P/12-
7NGK-12/L compared to the P/12-7NH-12/L nanoparti-
cles (Figure 6).
Transmission electron microscopy (TEM) imaging
Particle shape and particle aggregation behavior can also
influence the gene expression of nanoparticles. Micro-
graphs of the P/12-7NH-12/L and P/12-7NGK-12/L
nanoparticles showed consistency with the previous
light scattering measurement, with particles of 100-150
nm in diameter being observed. The TEM images
showed no aggregation behavior of the particles (Figure
10). However, the P/12-7NGK-12/L nanoparticles were
found to be more cylindrical shaped, while the P/12-
7NH-12/L particles showed spherical morphology.
Discussion
In non-viral gene delivery, cellular uptake of the DNA
nanoparticles can influence the overall gene expression
due to the number of particles that are internalized and
the intracellular trafficking of the engulfed particle. In
our previous work, we found that glycyl-lysine substitu-
tion in the spacer region of the gemini surfactants
improved gene expression, and the transfection effi-
ciency correlated with DNA binding properties of
gemini surfactants [21]. In this study, we evaluated
whether the pathway of the cellular uptake of the P/12-
7NH-12/L and P/12-7NGK-12/L nanoparticles in Sf 1
Ep cells is a major factor affecting the transfection effi-
ciency of these novel delivery systems. Clathrin-
mediated uptake, caveolae-mediated uptake and macro-
pinocytosis are known to be three of the most important
uptake pathways in mammalian cells [4]. Treatment
with chemical inhibitors such as genistein, filipin,
methyl-b-cyclodextrin, chlorpromazine, wortmannin,
and potassium free buffer are routinely used to deter-
mine the effect of each pathway on cellular uptake of
nanoparticles [8,12,22-24]. Upon treatment of the Sf 1
Ep cells with these chemicals at different concentrations,
we selected those agents that showed high cell viability
with no significant difference among the inhibitors, thus
minimizing the impact of the agents on the overall gene
expression. Conditions regarding concentration of the
inhibitor and incubation time that retained cell viability
greater than 80% were selected for further experiments
(Figure 3). In previous studies, we found that the P/G/L
nanoparticles were safe, inducing minimal toxicity (9-
12%) to the cells [21]; however, the combined toxicity of
P/G/L nanoparticles and chemical inhibitors/potassium
depletion was unknown. The cell toxicity induced by the
chemical treatment in the presence of P/G/L nanoparti-
cles increased to 30-40% (Figure 4). Without a signifi-
cant difference in the toxicity among various agents, the
cellular uptake study in Sf 1 Ep cells was found to pro-
vide meaningful insight of the mechanism of uptake and
shed light on the crucial relationship between the physi-
cochemical parameters and the difference in the trans-
fection efficiency of the parent and glycyl-lysine
substituted gemini nanoparticles.
In the cellular uptake study using CLSM, it was
observed that the inhibition of caveolae-mediated (genis-
tein) or clathrin-mediated (chlorpromazine) uptake did
not influence significantly the uptake of P/12-7NGK-12/
L or P/12-7NH-12/L nanoparticles. However, no parti-
cles were internalized upon inhibition of both clathrin-
mediated and caveolae-mediated pathways, simulta-
neously, by methyl-b-cyclodextrin (Figure 5D &5I). This
suggests that P/G/L nanoparticles were able to recruit
both clathrin-mediated and caveolae-mediated uptake.
In previous studies, cationic lipid-DNA complexes
(using DOTAP and SAINT-2/DOPE) have been sug-
gested to preferentially internalize via clathrin-mediated
endocytosis [22,25]. However, more recent studies
emphasized that the physiochemical parameters of the
DNA complexes (such as particle size, shape and surface
chemistry) as well as cell type can influence the uptake
behavior [26-28]. Polyethylenimine (PEI)/DNA com-
plexes were found to internalize via clathrin- or caveo-
lae-mediated mechanisms depending on both PEI type
(linear or branched) and cell line [28]. Interestingly,
A  B 
Figure 10 Transmission electron microscopy (TEM) images of
P/G/L complexes. (A) P/12-7NH-12/L nanoparticles (B) P/12-7NGK-
12/L nanoparticles. P/12-7NGK-12/L nanoparticles are cylindrical
while P/12-7NH-12/L are spherical in shape. Scale bar corresponds
to 200 nm.
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DNA complexes found macropinocytosis to be the
major pathway leading to gene transfection in CHO
cells [29]. Caveolae-mediated uptake was also found to
be important for transfection of human serum albumin
coated DOTAP/DOPE complexes [30]. In the present
study, the role of caveolae-mediated uptake in cationic
gemini surfactant based DNA nanoparticles was con-
firmed by a drop in gene expression in cells transfected
with P/12-7NH-12/L in the presence of genistein and
filipin, 54% (genistein) and 83% (filipin), compared to
the control. Inhibition of clathrin-mediated uptake
(chlorpromazine, potassiumd e p l e t i o n )d i dn o tr e d u c e
the gene expression of P/12-7NH-12/L; on the contrary,
it led to an increase (more than double) in gene expres-
sion. There may be two reasons for this: (a) inhibition
of the clathrin-mediated uptake results in an up-regula-
tion of other uptake pathways as observed in certain
mammalian cell types [31] or (b) inhibition of the cla-
thrin-mediated pathway leads to the availability of more
nanoparticles to follow the caveolae-mediated uptake, or
a combination of both. P/12-7NH-12/L nanoparticles
following the intracellular route via clathrin-mediated
uptake may not be contributing substantially in overall
gene expression. No gene expression was observed upon
inhibition of both clathrin-mediated and caveolae-
mediated pathway by methyl-b-cyclodextrin. Macropino-
cytosis (wortmannin) had no significant effect on the
gene expression in cells transfected with the P/12-7NH-
12/L nanoparticles. While there was only a modest
decrease in the gene expression in the P/12-7NGK-12/L
transfected cells after inhibition of clathrin- or caveolae-
mediated uptake, gene expression decreased by 93%
when both pathways were blocked simultaneously by
methyl-b- c y c l o d e x t r i n .T h i ss u g g e s t st h a tP / 1 2 - 7 N G K -
12/L nanoparticles can be internalized via either cla-
thrin-mediated or caveolae-mediated routes, are able to
avoid degradation, and release DNA at appropriate time
for successful gene expression.
Analysis of gene expressions also pointed to an inter-
esting fact: glycyl-lysine substitution not only improved
the overall transfection efficiency of P/12-7NGK-12/L
but also the gene expression level via each route (cla-
thrin-mediated or caveolae-mediated) was higher than
P/12-7NH-12/L. This difference in gene expression may
be due to the number of particles that are internalized
or improved endosomal escape of P/12-7NGK-12/L par-
ticles. Particle size and shape may affect cellular uptake,
significantly [27]. As reported previously, the particle
size of the P/12-NGK-12/L and P/12-NH-12/L nanopar-
ticles was 117.3 ± 0.6 nm and 133.0 ± 2.8 nm, respec-
tively [20]. The smaller particle size of P/12-7NGK-12/L
might be advantageous in improving the rate of cellular
uptake. Rod-like or cylinder shaped particles were found
to be internalized faster than the spherical particles [27].
The effect of cylindrical morphology is more significant
on the cellular uptake when the aspect ratio (diameter
to width) is high, especially in particles with diameter >
150 nm [27]. TEM images showed that P/12-7NH-12/L
particles were cylindrical while P/12-7NGK-12/L parti-
cles were spherical (Figure 10). A large number of parti-
cles ensure availability of more DNA particles inside the
cell. However, this does not guarantee higher gene
expression since the DNA can be degraded in the cyto-
sol. Therefore, we further analyzed the important physi-
cochemical properties that may be contributing to more
efficient intracellular trafficking of these nanoparticles.
Glycyl-lysine substitution improves endosomal escape in
clathrin-mediated pathway
Intracellular trafficking of an engulfed particle is influ-
enced by the type of uptake. In clathrin-mediated endo-
cytosis, the nanoparticles are entrapped in endosomes,
transported to late endosomes, and finally merged with
lysosomes for complete degradation. This latter step,
degradation of the genetic material in the lysosomes,
can significantly decrease the overall availability of plas-
mid DNA for translocation to the nucleus for gene
expression [32]. However, several scenarios can be envi-
sioned to overcome this challenge by utilization of an
interesting phenomenon that happens during the trans-
fer of cargo from early endosomes to late endosomes. In
mammalian cells, there is an early drop in pH in the
clathrin-coated endosomes as they travel towards the
late endosomes, creating strong acid conditions before
merging with the lysosomes [6]. These conditions can
be used in an advantageous manner by designing pH-
sensitive delivery vectors that can either absorb H
+-ions
or unfold (relax) in an acidic environment. In the for-
mer case, a significant increase in H
+-ions will trigger
an increased inflow of aqueous medium leading to swel-
ling and then bursting of endosomes, releasing the DNA
nanoparticles into the cytoplasm [33]. In the latter case,
the nanoparticles can unfold and increase their size, sig-
nificantly, leading to a mechanical disruption of the
endosomal membrane and rescuing the DNA from lyso-
somal degradation [34].
In the clathrin-mediated uptake, we found that buffer-
ing capacity (Figure 8) and particle size increment (Fig-
ure 7) over neutral to acidic pH may be two important
properties that could be causing P/12-7NGK-12/L nano-
particles to escape more efficiently than the P/12-7NH-
12/L, and lead to timely release of plasmid for nuclear
localization and gene expression. In the slow but steady
decrease of pH, the P/12-7NGK-12/L nanoparticles
could absorb more protons triggering an inflow of Cl
-.
The flow of ions also brings more fluid inside the endo-
somal vesicle, ultimately leading to its breakdown and
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supported by the fact that, at physiological pH, the size of
the P/12-7NGK-12/L nanoparticles was 119.5 ± 4.8 nm
which then increased significantly with a drop in pH (Fig-
ure 7). Maximum particle size of 144.8 ± 5.9 nm was
found at strongly acidic conditions (~pH 4), a net
increase of 21.2% compared to the original particle size.
On the other hand, the parent compound had a particle
size of 128.6 ± 0.6 nm at physiological pH with a maxi-
mum size of 136.7 ± 0.3 nm around 5-5.5 pH (Figure 8).
This is an overall increase of only 6.3% compared to the
original particle size which may not have been instru-
mental in endosomal escape. The decrease in pH in the
endosomes could allow for additional interaction with
the endosomal membrane and promote DNA escape/
release (Figure 11). This increase in particle size could be
an indication of the relaxation of the nanoparticles; facili-
tating the availability of more 12-7NGK-12 molecules for
absorption of H
+, thus, increasing overall buffering capa-
city of the system. The increase in particle size may also
be an indication of reduced interaction between the
DNA and 12-7NGK-12, facilitating DNA release from
the complexes after endosomal escape, as suggested by
increased ethidiun bromide intercalation in the presence
of high concentrations of polyanion (Figure 9).
Glycyl-lysine substitution improves DNA/gemini
surfactant binding properties
Previously, we found that DNA/gemini surfactant inter-
actions play a crucial role in gene delivery ability of
these molecules [21]. Conformational flexibility achieved
by insertion of a glycine moiety as a linking molecule
between the spacer region and terminal lysine lead to a
balance between DNA binding and release behavior of
the P/12-7NGK-12/L nanoparticles. In this study, we
further explored this idea in the context of intracellular
trafficking following caveolae-mediated uptake of the P/
G/L nanoparticles.
In caveolae-mediated uptake, there is no gradual pH
transition that could influence the interaction between
the gemini surfactants and DNA. Therefore, we
mimicked this pathway by evaluating the behavior of the
Figure 11 Intracellular trafficking of P/G/L complexes via clathrin-mediated pathway. A schematic comparison of crucial steps in
endosomal escape of P/12-7NGK-12/L (on the left side of the image) and P/12-7NH-12/L (on the right side of the image) nanoparticles in
clathrin-mediated cellular uptake.
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which could potentially compete for the cationic charges
on the gemini surfactants with the DNA, and deter-
mined its effect on DNA binding properties of the
gemini surfactants (Figure 12). We found that low con-
centrations of heparin with P/12-7NGK-12/L did not
affect binding of the gemini surfactant to DNA, signifi-
cantly, compared to nanoparticles formulated with the
parent gemini surfactant. The shielding is crucial for the
initial interaction of P/G/L nanoparticles with the cell
surface membrane and uptake without premature
release of the DNA at the cell surface. However, at
higher concentration of heparin, the accessibility of the
DNA in P/12-7NGK-12/L increased significantly (Figure
9). This suggests that the 12-7NGK-12/L lipid system
provides balanced DNA binding properties that enable
the 12-7NGK-12/L system to protect the DNA as well
as interact readily with the anionic proteins coating the
inner surface of the caveolae-mediated vesicle (endo-
some). This balance may be instrumental in the efficient
disruption of vesicle membrane leading to DNA escape.
Conclusion
Amino-acid substitution in the spacer of the gemini sur-
factant did not alter the cellular uptake pathway,
showing a similar pattern to the unsubstituted parent
gemini surfactant. Both clathrin-mediated and caveolae-
mediated pathways were equally important routes of
uptake for P/G/L nanoparticles. Glycyl-lysine substitu-
tion in the gemini spacer improved buffering capacity
and imparted a pH-dependent increase of particle size.
This property conferred to the P/12-7NGK-12/L nano-
particles the ability to escape efficiently from clathrin-
mediated endosomes and leads to higher transfection
efficiency compared to the parent gemini surfactant.
More balanced binding properties (protection and
release) of P/12-7NGK-12/L in the presence of polya-
nions play an important role in the release of nanoparti-
cles internalized via caveolae-mediated uptake. These
factors (balanced binding properties and improved intra-
cellular endosomal escape) will be taken into considera-
tion in the design of further structural modifications,
such as attachment of other basic amino acids via glycyl
linkage to the gemini surfactants of the P/G/L
nanoparticles.
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